Rankings
▼
Calendar
BCYC Q3 2025 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$374M
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$12M
+338.5% YoY
Gross Profit
$12M
100.0% margin
Operating Income
-$66M
-558.6% margin
Net Income
-$59M
-503.7% margin
EPS (Diluted)
$-0.85
QoQ Revenue Growth
+301.8%
Cash Flow
Operating Cash Flow
-$71M
Free Cash Flow
-$72M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$764M
Total Liabilities
$145M
Stockholders' Equity
$618M
Cash & Equivalents
$648M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$12M
$3M
+338.5%
Gross Profit
$12M
-$43M
+127.3%
Operating Income
-$66M
-$64M
-2.7%
Net Income
-$59M
-$51M
-16.3%
← Q2 2025
All Quarters